Literature DB >> 14749630

Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women.

Victoria L Handa1, Elizabeth Garrett, Susan Hendrix, Ellen Gold, John Robbins.   

Abstract

OBJECTIVE: The purpose of this study was to describe the natural history of pelvic organ prolapse after menopause. STUDY
DESIGN: Over 2 to 8 years, participants in the estrogen plus progestin trial of the Women's Health Initiative at the University of California Davis had annual pelvic examinations, with an assessment of uterine prolapse, cystocele, and rectocele. The findings from these examinations were used to describe the incidence of pelvic organ prolapse, the probability of progression or regression, and the associated risk factors.
RESULTS: At baseline, 31.8% of women had pelvic organ prolapse (n=412 women). The annual incidences of cystocele, rectocele, and uterine prolapse were 9.3, 5.7, and 1.5 cases per 100 women-years, respectively. Incident prolapse was associated with increasing parity and waist circumference. The progression rates for grade 1 pelvic organ prolapse (per 100 women-years) were 9.5 for cystocele, 13.5 for rectocele, and 1.9 for uterine prolapse. The annual rates of regression (per 100 women-years) was 23.5, 22, and 48, respectively.
CONCLUSION: Our data suggest that pelvic organ prolapse is not always chronic and progressive as traditionally thought. Spontaneous regression is common, especially for grade 1 prolapse.

Entities:  

Mesh:

Year:  2004        PMID: 14749630     DOI: 10.1016/j.ajog.2003.07.017

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  79 in total

Review 1.  Genital prolapse in women.

Authors:  Joseph Loze Onwude
Journal:  BMJ Clin Evid       Date:  2012-03-14

2.  Short-term natural history in women with symptoms indicative of pelvic organ prolapse.

Authors:  Ann Miedel; Marion Ek; Gunilla Tegerstedt; Marianne Mæhle-Schmidt; Olof Nyrén; Margareta Hammarström
Journal:  Int Urogynecol J       Date:  2010-10-20       Impact factor: 2.894

3.  Longitudinal changes in pelvic organ support among parous women.

Authors:  Christopher B Pierce; Jennifer L Hallock; Joan L Blomquist; Victoria L Handa
Journal:  Female Pelvic Med Reconstr Surg       Date:  2012 Jul-Aug       Impact factor: 2.091

4.  Uterosacral vault suspension (USLS) at the time of hysterectomy: laparoscopic versus vaginal approach.

Authors:  Sara Houlihan; Shunaha Kim-Fine; Colin Birch; Selphee Tang; Erin A Brennand
Journal:  Int Urogynecol J       Date:  2018-11-05       Impact factor: 2.894

5.  Variability of current symptoms in women with pelvic organ prolapse.

Authors:  Vivian W Sung; Melissa A Clark; Eric R Sokol; Charles R Rardin; Deborah L Myers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-18

6.  Prevalence of symptomatic pelvic organ prolapse in a Swedish population.

Authors:  Gunilla Tegerstedt; Marianne Maehle-Schmidt; Olof Nyrén; Margareta Hammarström
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-06-29

Review 7.  Uterine prolapse.

Authors:  Anjum Doshani; Roderick E C Teo; Christopher J Mayne; Douglas G Tincello
Journal:  BMJ       Date:  2007-10-20

Review 8.  Surgery for posterior vaginal wall prolapse.

Authors:  Mickey Karram; Christopher Maher
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

9.  Diagnosis and Therapy of Female Pelvic Organ Prolapse. Guideline of the DGGG, SGGG and OEGGG (S2e-Level, AWMF Registry Number 015/006, April 2016).

Authors:  K Baeßler; T Aigmüller; S Albrich; C Anthuber; D Finas; T Fink; C Fünfgeld; B Gabriel; U Henscher; F H Hetzer; M Hübner; B Junginger; K Jundt; S Kropshofer; A Kuhn; L Logé; G Nauman; U Peschers; T Pfiffer; O Schwandner; A Strauss; R Tunn; V Viereck
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

10.  Pelvic organ support among primiparous women in the first year after childbirth.

Authors:  Victoria L Handa; Ingrid Nygaard; Kimberly Kenton; Geoffrey W Cundiff; Chiara Ghetti; Wen Ye; Holly E Richter
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.